Tarsus Pharmaceuticals Appoints New Chief Medical Officer
Company Announcements

Tarsus Pharmaceuticals Appoints New Chief Medical Officer

Don't Miss out on Research Tools:

The latest announcement is out from Tarsus Pharmaceuticals ( (TARS) ).

Tarsus Pharmaceuticals appointed Elizabeth Yeu, M.D. as Chief Medical Officer, effective November 4, 2024. Dr. Yeu, a prominent figure in ophthalmology, resigns from the board to focus on her new role. Her compensation package includes a base salary, bonuses, and stock options. The agreement also outlines severance and change in control benefits, ensuring security in her position. This strategic move highlights the company’s commitment to advancing its medical leadership.

For a thorough assessment of TARS stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyTarsus Pharmaceuticals price target raised to $41 from $36 at Goldman Sachs
TheFlyTarsus Pharmaceuticals price target raised to $73 from $61 at H.C. Wainwright
TheFlyTarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App